Olaparib in PALB2 Advanced Pancreatic Cancer
NCT06078787
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
16
Enrollment
OTHER
Sponsor class
Conditions
Advanced Pancreatic Cancer
Metastatic Pancreatic Cancer
Interventions
DRUG:
Olaparib 150 MG
Sponsor
Azienda Ospedaliero-Universitaria di Modena